Board meetings, strategic plans, and buyer signals from Katherine A DuMond’s organization
May 21, 2026·BoardMeeting
Board
Medicaid Advisory Committee Quarterly Meeting
The meeting agenda includes a review of the Medicaid provider list for FFS, the 2026 Access Monitoring Review Plan, and discussions regarding veterans, Group VIII, pending legislation, and regulatory actions concerning Medicaid management care and federal audits. Additionally, the committee will discuss Medicaid expansion, presumptive eligibility for qualified entities, the annual report for July 2026, public comments, new business, and the nomination of a new Vice Chair.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
The meeting agenda covers various administrative and clinical matters, including the review of health plan policies and the presentation of a DUR Committee report. Specific clinical topics include re-reviewing interventions related to Montelukast, asthma medication ratios, and COPD controller inhalers. The committee will also evaluate recent interventions involving antiretroviral non-adherence, benzodiazepine monotherapy, and heart failure management, as well as a new intervention concerning antipsychotic metabolic monitoring. Additionally, the meeting will include reports on MAT and opioid usage, and the coordinated services program.
Apr 30, 2026·BoardMeeting
Board
Ohio Department of Medicaid Beneficiary Advisory Council Meeting Minutes
The committee discussed several items, including the introduction of new members and the new Director, Scott Partika. Key administrative matters included planning for future officer elections and a review of website navigation improvements, with specific suggestions for sorting search results by date and including a reference publication for acronyms. Several presentations, such as the MyCare rollout and long-term care Medicaid, were either deferred or postponed due to time constraints. Additionally, the committee decided to move to a monthly meeting cadence, with every other month dedicated to discussion-only sessions to improve productivity.
Apr 8, 2026·BoardMeeting
Board
Ohio Department of Medicaid Pharmacy And Therapeutics Committee Agenda
The agenda includes administrative matters, department policy updates, and presentations from drug manufacturers and interested parties. A primary focus is the review of Unified Preferred Drug List (UPDL) proposals covering therapeutic categories such as analgesic agents, cardiovascular agents, central nervous system agents, immunomodulator agents, and respiratory agents. Additionally, the committee will discuss other business items related to anti-migraine, diabetes, and metabolic modifier agents.
Extracted from official board minutes, strategic plans, and video transcripts.
